CTOs on the Move

Mission Bio

www.missionbio.com

 
Mission Bio is a company of passionate people dedicated to solving complex biological problems with precision engineering, innovative biochemistry, and supported bioinformatics.
  • Number of Employees: 25-100
  • Annual Revenue: $0-1 Million
  • www.missionbio.com
  • 6000 Shoreline Court Suite 204
    South San Francisco, CA USA 94080
  • Phone: 415.854.0058

Executives

Name Title Contact Details

Funding

Mission Bio raised $10M on 10/17/2017
Mission Bio raised $28.4M on 07/11/2018
Mission Bio raised $30M on 12/13/2018
Mission Bio raised $70M on 08/13/2020

Similar Companies

Matinas BioPharma

Matinas BioPharma is a clinical-stage biopharmaceutical company focused on development of its lead product candidate, MAT9001, for the treatment of cardiovascular and metabolic conditions. MAT9001 is a prescription-only omega-3 fatty acid-based composition, comprised primarily of EPA and DPA, under development for hypertriglyceridemia, that was specifically designed to overcome the shortcomings seen from other agents in the omega-3 class. Company leadership has a deep history and knowledge of cardiovascular drug development and is supported by a world-class team of scientific advisors. The company will soon begin enrolling MAT9001 in a confirmatory head-to-head PK/PD study vs Vascepa, after having shown superiority versus Vascepa® (icosapent ethyl) in reducing serum triglycerides, Total- and Non-HDL-Cholesterol, apolipoprotein CIII and PCSK9 levels in a previous study, with data expected in Q42020. In addition, the Company is developing MAT2203, an oral, encochleated formulation of Amphotericin B, to treat serious invasive fungal infections. The drug is based on Matinas` proprietary lipid nano-crystal (“LNC”) platform technology which can help solve complex challenges relating to the safe and effective delivery of potent medicines, potentially making them more targeted, less toxic and orally bioavailable.

deCODE genetics

deCODE genetics is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

INmuneBIO

INmune Bio Inc. is a clinical stage immuno-oncology company focused on harnessing the patient`s immune system to treat cancer. INKmune, the company`s lead product, primes patient`s NK cells (natural killer cells) to kill cancer.

20/20 GeneSystems Inc

20/20 GeneSystems Inc is a Rockville, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.